Shen et al. (2013) demonstrated that the inhibition of Wnt/β-catenin signaling leads to the downregulation of P-gp and decreases the efflux of P-gp substrates in cholangiocarcinoma [49]. The gene discussed is PGP; the disease is cholangiocarcinoma.